V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250000771 | 250008905 | 1.68 | 61.9 | Palliative (P) | 2021-02-11 | 2021-02-24 | null | N | N | TIVOZANIB | 101609837 |
| 250001057 | 250008910 | 1.69 | 63.5 | null | 2020-03-28 | 2020-04-20 | null | N | null | CARBOPLATIN + PACLITAXEL | 101410777 |
| 250001074 | 250008911 | 1.69 | null | Curative (C) | null | 2017-11-28 | CISPLATIN + FLUOROURACIL | 02 | null | ATEZOLIZUMAB | 100864065 |
| 250001092 | 250008912 | null | null | null | null | 2020-05-02 | null | null | null | CARBOPLATIN + PACLITAXEL | 100809939 |
| 250001115 | 250008913 | 1.59 | 66.2 | Palliative (P) | 2021-02-25 | 2021-02-26 | null | 02 | N | CARBOPLATIN + PEMETREXED | 101513283 |
| 250001134 | 250008915 | 1.69 | 0 | Palliative (P) | 2018-11-23 | 2018-12-21 | Carboplatin + Paclitaxel (3 weekly) | 02 | Y | TRIAL UNSPECIFIED | 100538026 |
| 250001208 | 250008916 | 1.65 | 60.15 | null | null | 2019-10-26 | null | 02 | N | IMATINIB | 101544258 |
| 250001358 | 250008918 | 1.76 | 54.9 | null | null | 2019-10-22 | VAC | N | null | TRIAL UNSPECIFIED | 100992873 |
| 250001607 | 250008919 | null | null | null | null | 2022-03-29 | Trial Unspecified | null | N | CARBOPLATIN | 100796180 |
| 250001692 | 250008922 | 1.65 | 66.7 | Palliative (P) | 2021-10-30 | 2021-10-30 | null | 02 | N | CAPECITABINE + OXALIPLATIN | 100928227 |
| 250001892 | 250008925 | null | 100 | null | 2020-08-21 | 2020-08-23 | CETUXIMAB | 02 | N | CAPECITABINE + OXALIPLATIN | 101074705 |
| 250002014 | 250008926 | 1.69 | 109.6 | Curative (C) | null | 2020-08-09 | null | N | null | PAZOPANIB | 100115437 |
| 250002352 | 250008929 | 1.71 | 10.4 | Palliative (P) | null | 2020-04-12 | CARBO + FLUOROURACIL | 01 | N | CISPLATIN + RT | 100092336 |
| 250001320 | 250008930 | 1.6 | 99.4 | Palliative (P) | null | 2018-02-25 | Trabectedin | 02 | N | CARBOPLATIN + PACLITAXEL | 100015616 |
| 250001986 | 250008931 | 1.67 | 105.9 | Palliative (P) | 2018-12-05 | 2018-12-05 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | CETUXIMAB | 100407895 |
| 250002073 | 250008932 | 1.33 | 64 | null | 2020-05-05 | 2020-05-14 | null | 02 | N | ATEZOLIZUMAB | 101020099 |
| 250001545 | 250008982 | 1.75 | 93.6 | null | null | 2022-02-09 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100199934 |
| 250001558 | 250008983 | 1.57 | 62.5 | null | null | 2018-11-05 | null | null | null | CARBOPLATIN + GEMCITABINE | 101773875 |
| 250001639 | 250008985 | null | 73.9 | null | null | 2019-06-13 | CISPLATIN + GEMCITABINE | null | null | CISPLATIN + GEMCITABINE | 101341015 |
| 250001674 | 250008986 | 1.71 | 115.9 | Palliative (P) | 2017-03-15 | 2017-03-20 | null | 02 | N | NIVOLUMAB | 101494040 |
| 250001680 | 250008987 | 1.73 | 104 | Palliative (P) | null | 2018-09-06 | CARBOPLATIN + GEMCITABINE | null | Y | CARBOPLATIN + GEMCITABINE | 101211758 |
| 250001695 | 250008988 | 1.53 | 50.4 | null | null | 2019-07-07 | GEMCARBO | null | null | CARBOPLATIN + GEMCITABINE | 101389877 |
| 250001854 | 250008990 | 1.89 | 60.2 | Palliative (P) | 2020-03-06 | 2020-03-08 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100286887 |
| 250001954 | 250008991 | 1.67 | 85.4 | null | null | 2020-02-11 | GemCarbo Days 1+8 | null | null | CARBOPLATIN + GEMCITABINE | 101216449 |
| 250001960 | 250008993 | 1.62 | 62 | Neo-adjuvant (N) | 2020-12-28 | 2021-01-11 | null | 02 | null | CISPLATIN + GEMCITABINE | 101408256 |
| 250001973 | 250008994 | 1.74 | 95.5 | null | null | 2021-10-09 | null | null | null | CISPLATIN + GEMCITABINE | 100997981 |
| 250002027 | 250008996 | 1.66 | 148.2 | null | 2018-07-02 | 2018-10-31 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101518277 |
| 250002083 | 250008999 | 1.83 | 61 | Palliative (P) | 2019-11-30 | 2019-12-10 | CISPLATIN + GEMCITABINE | 02 | N | PEMBROLIZUMAB | 101586927 |
| 250002107 | 250009001 | 1.84 | 70.8 | Palliative (P) | 2019-07-14 | 2019-07-15 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 100626278 |
| 250002130 | 250009002 | 1.69 | 55.4 | null | null | 2020-12-04 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100761352 |
| 250002153 | 250009004 | 1.72 | 81.9 | Palliative (P) | 2021-12-13 | 2021-12-31 | null | null | N | PEMBROLIZUMAB | 100292841 |
| 250002254 | 250009014 | 1.53 | 78.1 | Adjuvant (A) | 2020-08-22 | 2020-08-23 | CISPLATIN + GEMCITABINE | 02 | N | NIVOLUMAB | 100575057 |
| 250002263 | 250009015 | 1.66 | 56 | null | null | 2018-03-09 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100975579 |
| 250002272 | 250009016 | 1.78 | 53.8 | null | 2019-04-09 | 2020-01-30 | null | 02 | null | CARBOPLATIN + GEMCITABINE | 100196390 |
| 250002280 | 250009019 | 1.77 | 0 | null | null | 2017-03-10 | CARBOPLATIN + GEMCITABINE | null | null | CARBOPLATIN + GEMCITABINE | 100171267 |
| 250002294 | 250009020 | 1.78 | 55 | Palliative (P) | 2017-12-05 | 2018-09-22 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101014106 |
| 250002334 | 250009026 | 1.63 | 105.9 | Palliative (P) | null | 2020-03-12 | null | 02 | Y | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 101637139 |
| 250002335 | 250009027 | null | 0 | Palliative (P) | null | 2020-05-23 | null | 02 | N | ENZALUTAMIDE | 100304734 |
| 250002344 | 250009028 | null | 0 | null | 2022-05-27 | 2022-05-30 | Atezolizumab + Bevacizumab + Carboplatin + Paclitaxel | 02 | null | DOCETAXEL | 101069981 |
| 250002405 | 250009034 | 1.65 | 88 | Palliative (P) | 2018-12-22 | 2018-12-23 | null | 02 | N | ENZALUTAMIDE | 100133184 |
| 250002410 | 250009036 | null | null | Palliative (P) | 2020-07-27 | 2020-07-27 | Trial Unspecified | 02 | null | DOCETAXEL | 101773111 |
| 250002412 | 250009037 | 1.63 | 66.7 | null | 2018-10-09 | 2018-11-19 | DOXORUBICIN | 02 | N | CARBOPLATIN + PACLITAXEL | 101613599 |
| 250002414 | 250009038 | 1.64 | 56 | Curative (C) | null | 2020-06-11 | Trabectedin | 02 | N | CARBOPLATIN | 100241738 |
| 250002430 | 250009039 | 1.6 | 56.6 | null | 2019-10-21 | 2019-10-21 | Irinotecan weekly | 02 | null | FLUOROURACIL + IRINOTECAN | 100584231 |
| 250002434 | 250009040 | 1.87 | 62 | Palliative (P) | 2020-01-13 | 2020-02-03 | null | 02 | null | TIVOZANIB | 101792055 |
| 250002460 | 250009041 | 1.65 | 61 | null | 2021-12-13 | 2021-12-15 | null | 02 | N | CISPLATIN + FLUOROURACIL | 100235580 |
| 250002496 | 250009044 | 1.65 | 73 | Neo-adjuvant (N) | 2021-02-19 | 2021-08-06 | CARBOPLATIN + VINORELBINE | 02 | N | NB HRNBL-1 COJEC IND COURSE A | 101022174 |
| 250002502 | 250009045 | 1.68 | 72 | Palliative (P) | null | 2022-03-19 | Trial Unspecified | 02 | N | CARBOPLATIN + FLUOROURACIL | 100633098 |
| 250002509 | 250009048 | 1.7 | 71 | Palliative (P) | 2020-01-15 | 2020-01-18 | null | 02 | N | ENZALUTAMIDE | 100413560 |
| 250002529 | 250009052 | 1.7 | 73.8 | Palliative (P) | 2019-12-20 | 2020-01-20 | Capecitabine (21days) + Carboplatin | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100323076 |